Edwards Lifesciences (EW) Cash from Investing Activities Growth (1y) (2010 - 2026)
Edwards Lifesciences (EW) Cash from Investing Activities Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.94 Bn | 194.34 Bn | 7.27 Bn | -15.64% |
| 2 | Stryker | 129.96 Bn | 126.49 Bn | 4.50 Bn | -514.42% |
| 3 | Medtronic | 120.01 Bn | 110.79 Bn | 6.41 Bn | -87.14% |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | -73.71% |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.40 Bn | 1.35 Bn | -12.26% |
| 6 | Dexcom | 34.63 Bn | 32.68 Bn | 830.00 Mn | 618.55% |
| 7 | GE HealthCare Technologies | 34.02 Bn | 31.91 Bn | 2.18 Bn | 48.43% |
| 8 | Koninklijke Philips | 26.43 Bn | 23.11 Bn | 4.55 Bn | 91.33% |
| 9 | Steris | 23.18 Bn | 22.69 Bn | 684.20 Mn | 0.00% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 86.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.26% |
| Mar 31, 2026 | -208.79% |
| Dec 31, 2025 | 65.61% |
| Sep 30, 2025 | -115.83% |
| Jun 30, 2025 | -237.90% |
| Mar 31, 2025 | 35.18% |
| Dec 31, 2024 | -4,190.07% |
| Sep 30, 2024 | 2,935.62% |
| Jun 30, 2024 | 77.78% |
| Mar 31, 2024 | 12,520.00% |
| Dec 31, 2023 | -85.11% |
| Sep 30, 2023 | 144.17% |
| Jun 30, 2023 | -45.83% |
| Mar 31, 2023 | -99.78% |
| Dec 31, 2022 | 109.80% |
| Sep 30, 2022 | 46.61% |
| Jun 30, 2022 | 139.33% |
| Mar 31, 2022 | 561.77% |
| Dec 31, 2021 | -271.64% |
| Sep 30, 2021 | -198.81% |